OSRAM Opto Semiconductors, X-Celeprint Enter into License Agreement Covering Micro Transfer Printing
OSRAM Opto Semiconductors recently entered into a technology and patent license agreement with X-Celeprint. The agreement covers X-Celeprint’s micro transfer printing technology.
“With this technology, we will be able to develop LED products meeting the requirements for more and more functionality on very small areas.
Furthermore, it offers new innovative approaches to combine different technologies fast and precisely”, says Dr. Martin Behringer, head of the chip pre-development at OSRAM Opto Semiconductors.
Demo of X-Celeprint's Micro Transfer Technology (μTP) (Video: X-Celeprint)
Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein<
Proprietary Rights
You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.
Violumas aims to provide the best variety of high-performance UVA, UVB, and UVC LEDs, encapsulated with the highest quality fused silica optics. The wide selection of beam angles (30°, 60°, 90°, 120°, and 135°) allows Violu... READ
MORE
J Series JB3030C White LEDs deliver high efficacy in a 301B/H compatible footprint to lighting applications that demand long lifetimes and sulfur resistance. Pro9™ versions of these LEDs deliver up to 13% higher efficacy over the standar... READ
MORE